By Elie Dolgin

In September 2008, Japan’s patent office issued the first license related to induced pluripotent stem (iPS) cells to Kyoto University’s Shinya Yamanaka. Ever since that decision, the stem cell community has waited with bated breath to see how other countries’ patent offices would resolve the hundreds of similar applications they’ve received. (Click here to continue reading)

Image: Junying Yu, University of Wisconsin–Madison